EPAC

Enerpac is a well-run, focused industrial-tools business and the numbers show it. The post-ASCEND earnings recovery is real and durable: net income has climbed from $15.7M (FY2022) to $46.6M, $85.7M and $92.7M over the following three years, while operating margin expanded to 21.6% and gross margin sits at a healthy 50.5%. MD&A confirms the ASCEND transformation delivered ~$54M of annual operating profit and was completed in August 2024 at $75M total cost — so the heavy lifting on cost-out is largely done, and operating profit still grew to $133M (22% of sales) in FY2025 on continued Lean/80-20 discipline. Returns on capital are excellent (ROE 21.4%), the balance sheet is conservative (liabilities/equity 0.91x, $152M cash against $182M long-term debt), and the company converts well — operating cash flow jumped 36.8% to $111M against just $19.3M of capex, funding $68.7M of buybacks that shrank the share count 2.2%.

The problem is not quality, it's price and pace. Top-line growth is only mid-single-digit (revenue +4.6% to $617M, and the FY2025 increase was partly flattered by a weaker U.S. dollar per MD&A), and the one-time margin step-up from ASCEND won't repeat at the same scale. At $35.49 the stock trades at 20.9x FY diluted EPS of $1.70 and 3.0x sales — a full multiple that already credits the company for its quality and capital discipline. With EPS growth of ~9% and limited revenue acceleration, the math leaves modest upside: the main forward engine is continued buybacks and incremental margin gains, not a re-rating.